大正製薬ホールディングス株式会社TSE 4581

大正製薬ホールディングス株式会社

Share price at FY-end
¥5,520
FY ending Mar 2023
Market cap at FY-end
¥470B
Dividend per share
¥100.0
Avg. director pay
¥39.3M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 公益財団法人上原記念生命科学財団 15,000,000 18.28% ¥82.8B ¥1.5B
2 上原 昭二 7,679,000 9.36% ¥42.4B ¥768M
3 日本マスタートラスト信託銀行株式会社 5,765,000 7.03% ¥31.8B ¥576M
4 公益財団法人上原美術館 3,900,000 4.75% ¥21.5B ¥390M
5 株式会社三井住友銀行 3,000,000 3.66% ¥16.6B ¥300M
6 株式会社三菱UFJ銀行 3,000,000 3.66% ¥16.6B ¥300M
7 上原 明 2,143,000 2.61% ¥11.8B ¥214M
8 株式会社日本カストディ銀行 1,853,000 2.26% ¥10.2B ¥185M
9 Kajima Corporation 1,650,000 2.01% ¥9.1B ¥165M

Officers' holdings and pay

NameTitleSharesValuePay
上原 明 President & Representative Director 2,143,500 ¥11.8B —
上原 茂 Executive Vice President & Director 1,034,200 ¥5.7B —
上原 健 Director 1,034,200 ¥5.7B —
黒田 潤 Director 2,100 ¥11.6M —
渡邊 哲 Director 1,300 ¥7.2M —
北谷 脩 Director 3,150 ¥17.4M —
國部 毅 Director — — —
植村 裕之 Director — — —
亀尾 一弥 Audit & Supervisory Board Member 3,530 ¥19.5M —
生駒 武資 Audit & Supervisory Board Member 200 ¥1.1M —
青井 忠四郎 Audit & Supervisory Board Member — — —
松尾 眞 Audit & Supervisory Board Member 330 ¥1.8M —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2023 ¥5,520 ¥231.73 23.8x ¥100.0 85,139,000
FY ending Mar 2022 ¥5,680 ¥161.12 35.2x ¥100.0 85,139,000
FY ending Mar 2021 ¥7,141 ¥166.84 42.8x ¥100.0 85,139,000
FY ending Mar 2020 ¥6,639 ¥257.23 25.8x ¥110.0 85,139,000
FY ending Mar 2019 ¥10,550 ¥608.80 17.3x ¥120.0 90,139,000
FY ending Mar 2018 ¥10,461 ¥396.54 26.4x ¥110.0 90,139,000
FY ending Mar 2017 ¥9,040 ¥360.18 25.1x ¥110.0 90,139,000
Source: annual securities reports on EDINET. Values are estimates. Methodology